BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Sanofi ASCO Preview: Addressing Unmet Needs in Breast Cancer

  Sanofi’s experimental breast cancer treatment amcenestrant in combination with Pfizer’s Ibrance is showing promising anti-tumor activity in postmenopausal women with metastatic breast cancer.

  June 3, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Experts: Previous COVID-19 Infection Not a ‘Get Out Of Jail Free’ Card

  Importantly, the researchers recovered virus that they were able to culture, indicating a high risk for transmissibility.

  June 3, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Protagonist, Janssen Win Breakthrough Therapy Designation for Oncology Candidates

  Shares of Protagonist Therapeutics climbed nearly 4% in premarket trading after the company announced its lead drug candidate rusfertide snagged Breakthrough Therapy Designation from the U.S. FDA.

  June 3, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Novartis Breaks Through with Radioligand Therapy for Prostate Cancer

  Today, the Swiss pharma titan announced the results of its Phase III VISION study, where 177Lu-PSMA-617 plus best standard of care (SOC) met both of its primary endpoints.

  June 3, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Bio NC

  Research Roundup: A Complete Human Genome Sequenced and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  June 3, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  White House Science Chief Wants to Nullify Next Pandemic Within 100 Days

  The nation’s top science adviser believes the country’s renewed enthusiasm for science may pave the way for plug-and-play vaccines that can nullify the next pandemic before it starts.

  June 3, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Career Advice

  Growing Your Emotional Intelligence At Workplace to Become an Effective Employee

  Do you know that growing emotional intelligence at workplace can be beneficial for career growth? If not, have a look at the article and learn some tips.

  June 3, 2021

   · 

  4 min read

   · 

  Hannah Harshman
• 

  Career Advice

  Career Development Initiatives that Can Work in Favor of Millennials

  A well-designed career development program provides the right guidance and training for workers to improve their professional careers.

  June 3, 2021

   · 

  2 min read

   · 

  Brandi Marcene
• 

  Policy

  Pharma on Trial: Multiple Companies are in Legal Crosshairs

  AbbVie has been the target of multiple legal inquiries and challenges of its pricing and patent protections. Now, a U.S. senator is taking a gander at the company’s taxes.

  June 3, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Migraines Be Gone: AbbVie’s Atogepant Reduces Headache Frequency and Severity

  Migraine headaches can be reduced in frequency and severity by atogepant, an oral therapy developed by AbbVie. So migraines will be gone sooner than we think.

  June 3, 2021

   · 

  4 min read

   · 

  Gail Dutton